This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Recombinant Canine Interleukin-13 Receptor Subunit Alpha-2 (IL13RA2), C-Fc
Product Overview
BioVenic's Recombinant Canine Interleukin-13 Receptor Subunit Alpha-2 (IL13RA2), C-Fc is a recombinant protein expressed from HEK293 Cell. Its predicted molecular weight is 64.1 kDa. The purity is>95% (SDS-PAGE).
Specifications
Target Information
Canine Interleukin-13 Receptor Subunit Alpha-2 (IL13RA2) is a high-affinity membrane receptor for IL-13, overexpressed in various tumors such as gliomas. It functions as a decoy receptor to inhibit IL-13 and IL-4 signaling, modulating immune responses and inflammation. In veterinary medicine, IL13RA2 is a potential target for cancer immunotherapy, with cytotoxin therapies showing preliminary efficacy in canine glioma trials.
Shipping and Storage
This product is shipped with ice packs. Lyophilized protein can be stored at -20°C for 1 year. After reconstitution, the protein solution can be stored at 2-8°C for 2-7 days.
Documents
The product is for research use only.
Not for commercial, prophylactic, diagnostic, or therapeutic applications.
User Note
- Always centrifuge tubes before opening. Avoid mixing by vortexing or pipetting. Aliquot the reconstituted solution to minimize freeze-thaw cycles.